ONWD Onward Medical N.V.

EBR · BE · Healthcare · Biotechnology · onwd.com
1.528USD1.390 EUR · EBR-4.40%Mkt Cap: 106.23M USDP/E: —

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The compa…

Institutional holders6 on file

Key Statistics

Company
Market Cap106.23M USD
Enterprise Value31.80M USD
Revenue (TTM)9.26M USD
Gross Profit3.01M USD
Net Income (TTM)-45.93M USD
Revenue/Share0.17 USD
Last Price1.528 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees137
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINNL0015000HT4
Valuation
P/E (Trailing)—
P/E (Forward)-1.97
PEG—
EV/EBITDA-0.67
EV/Revenue3.44
P/S11.48
P/B1.34
EPS (TTM)-0.93 USD
EPS (Forward)-0.78 USD
52W Range
1.4861% of range5.265
52W High5.265 USD
52W Low1.486 USD
Profitability
Gross Margin72.51%
Oper. Margin-525.44%
EBITDA Margin0.00%
Profit Margin-1105.48%
ROE-75.54%
ROA-49.42%
ROIC-4697.59%
ROCE-55.70%
Growth
Revenue Growth253.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-42.94M USD
CapEx (TTM)474.85K USD
FCF Margin-345.15%
FCF Yield-30.07%
Net Debt-74.43M USD
Net Debt/EBITDA1.56
Net Debt/FCF—
Balance Sheet
Debt/Equity0.25
Current Ratio9.23
Quick Ratio8.60
Book Value/Sh1.14 USD
Cash/Share1.29 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.640 USD
Upside (mean)+465.5%
Target Range5.936 USD – 11.10 USD
5.936+465.5% to mean11.10
# Analysts5
Ownership
Shares Out.69.53M
Float54.66M
Insiders27.05%
Institutions23.41%
Technical
SMA 502.547 (-40.0%)
SMA 2003.054 (-50.0%)
Beta0.72
S&P 52W Chg8.68%
Avg Vol (30d)231.36K
Avg Vol (10d)211.19K
Technical Indicators
RSI (14)14.1
MACD-0.2219
MACD Signal-0.1938
MACD Hist.-0.0281
BB Upper2.620 USD
BB Middle2.026 USD
BB Lower1.431 USD
BB Width58.67%
ATR (14)0.1110 USD
Vol Ratio (20d)1.65x

About Onward Medical (EBR: ONWD)

›

Onward Medical (EBR: ONWD) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 137 employees.

The shares were at 1.390 EUR on 20 November 2026, down 65.0% over 52 weeks. Its 52-week range is 1.352 EUR to 4.790 EUR: the price is 71.0% below the high and 2.8% above the low.

Its market capitalisation is 96.65M EUR.

Onward Medical reports return on equity of -75.5% and revenue up 253.8% year over year.

It holds more cash than debt, a net cash position of 67.72M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 30 March 2027.